|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2000-2-29
|
|
pubmed:abstractText |
Large variations exist among hospitals in the use of treatment resources for community-acquired pneumonia (CAP). Lack of a common approach to the diagnosis and treatment of CAP has been cited as an explanation for these variations.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0098-7484
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
9
|
|
pubmed:volume |
283
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
749-55
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10683053-Aged,
pubmed-meshheading:10683053-Anti-Infective Agents,
pubmed-meshheading:10683053-Canada,
pubmed-meshheading:10683053-Community-Acquired Infections,
pubmed-meshheading:10683053-Critical Pathways,
pubmed-meshheading:10683053-Female,
pubmed-meshheading:10683053-Hospitalization,
pubmed-meshheading:10683053-Humans,
pubmed-meshheading:10683053-Male,
pubmed-meshheading:10683053-Middle Aged,
pubmed-meshheading:10683053-Ofloxacin,
pubmed-meshheading:10683053-Outcome Assessment (Health Care),
pubmed-meshheading:10683053-Pneumonia,
pubmed-meshheading:10683053-Sickness Impact Profile,
pubmed-meshheading:10683053-Statistics, Nonparametric
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.
|
|
pubmed:affiliation |
Department of Medicine, University of Alberta, Edmonton, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
